NCT02805855View on ClinicalTrials.gov

Autologous Culture Expanded Mesenchymal Stromal Cells for Knee Osteoarthritis

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 26, 2016

Primary Completion Date

September 28, 2023

Study Completion Date

September 28, 2023

Conditions

Osteoarthritis, Knee

Interventions

DRUG

Autologous Adipose-Derived Mesenchymal Stromal Cells

Human, autologous, culture expanded, adipose derived, mesenchymal stromal cells (AMSCs) produced on site in the Mayo Clinic Human Cellular Therapy Laboratory using current good manufacturing practices (cGMPs).

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

All Listed Sponsors

lead

Jacob L. Sellon, M.D.

OTHER

NCT02805855 - Autologous Culture Expanded Mesenchymal Stromal Cells for Knee Osteoarthritis | Biotech Hunter | Biotech Hunter